Millavelez, Cedrick G.

HRN: 29-04-35  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2026
AMPICILLIN 250MG (VIAL)
06/19/2026
06/25/2026
IV
235
Q12
PNEUMONIA
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: